Paulo Ricardo de Alencastro
Biographic Data
| ID | 10888335 |
|---|---|
| NAME | Paulo Ricardo de Alencastro |
| GIVEN NAMES | Paulo Ricardo de |
| FAMILY NAME | Alencastro |
| SIGNATURE | DE ALENCASTRO P R |
| AFFILIATIONS | Universidade Federal do Rio Grande do Sul |
| ORCID | 0000-0002-5134-1353 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 0 |
SP4-37 Metabolic syndrome prevalence and population attributable risk among HIV/Aids patients
Background Metabolic syndrome comprises a set of aggregated risk factors, which increase the risk of cardiovascular disease and type 2 diabetes mellitus, and changes in the abnormality criteria account for differences in prevalence rates and in the population attributable risk. Objectives Verify the prevalence of metabolic syndrome according to the NCEP-ATPIII, IDF and the AHA/NHLBI, and the impact of each component on the diagnostic of metabolic…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
No prominent works on this page.
SP4-37 Metabolic syndrome prevalence and population attributable risk among HIV/Aids patients
Background Metabolic syndrome comprises a set of aggregated risk factors, which increase the risk of cardiovascular disease and type 2 diabetes mellitus, and changes in the abnormality criteria account for differences in prevalence rates and in the population attributable risk. Objectives Verify the prevalence of metabolic syndrome according to the NCEP-ATPIII, IDF and the AHA/NHLBI, and the impact of each component on the diagnostic of metabolic…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
Cross-sectional study (2 works) · Diabetes, Cardiovascular Risks, and Lipoproteins (2 works) · HIV-related health complications and treatments (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Obesity (2 works) · Pathology (2 works) · Waist (2 works) · Abdomen (1 work)